2,112 Shares in Humana Inc. $HUM Purchased by Oslo Pensjonsforsikring AS

Posted by Stanley Muller on Jul 23rd, 2026

Oslo Pensjonsforsikring AS bought a new position in Humana Inc. (NYSE:HUM – Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 2,112 shares of the insurance provider’s stock, valued at approximately $366,000.

A number of other hedge funds have also added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its position in shares of Humana by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock valued at $3,652,890,000 after acquiring an additional 106,030 shares during the period. Capital International Investors increased its holdings in Humana by 113.9% during the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock worth $1,490,239,000 after acquiring an additional 3,097,571 shares during the period. Pzena Investment Management LLC increased its holdings in Humana by 34.3% during the 1st quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock worth $948,614,000 after acquiring an additional 1,398,774 shares during the period. State Street Corp lifted its stake in Humana by 1.8% in the 4th quarter. State Street Corp now owns 5,462,549 shares of the insurance provider’s stock worth $1,403,877,000 after purchasing an additional 97,211 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its stake in Humana by 28.9% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock worth $1,151,759,000 after purchasing an additional 1,008,514 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Price Performance

Shares of NYSE:HUM opened at $397.93 on Thursday. The company’s fifty day moving average price is $360.55 and its 200-day moving average price is $263.22. The firm has a market capitalization of $47.78 billion, a price-to-earnings ratio of 42.56, a PEG ratio of 2.20 and a beta of 0.71. Humana Inc. has a one year low of $163.11 and a one year high of $428.88. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77.

Humana (NYSE:HUM – Get Free Report) last posted its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The company had revenue of $39.65 billion during the quarter, compared to the consensus estimate of $39.37 billion. During the same period in the previous year, the firm posted $11.58 EPS. The firm’s revenue was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. On average, equities research analysts anticipate that Humana Inc. will post 9.46 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have recently commented on HUM. Guggenheim boosted their price target on shares of Humana from $252.00 to $269.00 and gave the company a “buy” rating in a research report on Thursday, April 30th. Royal Bank Of Canada increased their price objective on Humana from $246.00 to $415.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 9th. Leerink Partners lifted their price objective on Humana from $185.00 to $255.00 and gave the company a “market perform” rating in a research note on Thursday, April 30th. Evercore boosted their target price on Humana from $250.00 to $370.00 in a research report on Thursday, June 11th. Finally, JPMorgan Chase & Co. upped their target price on Humana from $214.00 to $316.00 and gave the stock a “neutral” rating in a research note on Monday, June 8th. Two analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating, fifteen have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $327.17.

Check Out Our Latest Stock Report on HUM

Humana Profile

(Free Report)

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

2,112 Shares in Humana Inc. $HUM Purchased by Oslo Pensjonsforsikring AS

Humana Price Performance

Analysts Set New Price Targets

Humana Profile

Further Reading

You might be interested in: